SCHEMBL29440642

SCHEMBL29440642

CCN(CC)c1ccc2ccc(=O)oc2c1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 1.00
KDM4E B2RXH2 5/20 1.00
GLA P06280 3/20 1.00
L3MBTL1 Q9Y468 3/20 1.00
CYP19A1 P11511 1/20 0.67
HPGD P15428 5/20 0.60
ATM Q13315 3/20 0.60
CYP3A4 P08684 2/20 0.60
HSD17B10 Q99714 2/20 0.60
IGLV6-57 P01721 2/20 0.60
MAPK1 P28482 1/20 0.60
CASP1 P29466 1/20 0.60
CASP7 P55210 1/20 0.60
HIF1A Q16665 1/20 0.60
MEN1 O00255 7/20 0.60
MAPT P10636 7/20 0.60
KMT2A Q03164 7/20 0.60
NPSR1 Q6W5P4 1/20 0.60
CYP1A2 P05177 3/20 0.59
CYP2C19 P33261 2/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL142022 1.00 ALDH1A1 (1.00) ALDH1A1KDM4EGLAL3MBTL1CYP19A1
Bromide SCHEMBL31261167 0.98 ALDH1A1 (0.97) ALDH1A1KDM4EGLAL3MBTL1CYP19A1
Formaldehyde SCHEMBL28369375 0.97 ALDH1A1 (0.94) ALDH1A1KDM4EGLAL3MBTL1CYP19A1
Cyanide SCHEMBL19972840 0.95 ALDH1A1 (0.91) ALDH1A1KDM4EGLAL3MBTL1CYP19A1
SCHEMBL10879416 0.91 ALDH1A1 (0.83) ALDH1A1KDM4EGLAL3MBTL1CYP19A1
SCHEMBL10004869 0.89 ALDH1A1 (0.78) ALDH1A1KDM4EGLAL3MBTL1CYP19A1
Trifluoroacetic Acid SCHEMBL30450517 0.89 ALDH1A1 (0.78) ALDH1A1KDM4EGLAL3MBTL1CYP19A1
SCHEMBL20348876 0.88 ALDH1A1 (0.79) ALDH1A1KDM4EGLAL3MBTL1CYP19A1
SCHEMBL29397438 0.87 ALDH1A1 (0.77) ALDH1A1KDM4EGLAL3MBTL1CYP19A1
SCHEMBL17731844 0.86 ALDH1A1 (0.74) ALDH1A1KDM4EGLAL3MBTL1CYP19A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250290918-A1 METHODS FOR ASSESSING CELL SURFACE GLYCOSYLATION JUNO THERAPEUTICS, INC. (US) 2025-09-18 US disclosed
US-12379375-B2 Methods for assessing cell surface glycosylation JUNO THERAPEUTICS, INC. (US) 2025-08-05 US disclosed
US-20250146923-A1 FLUORESCENCE AND/OR CHEMILUMINESCENCE DETECTION USING A PORTABLE DETECTOR IN HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC. 2025-05-08 US disclosed
CN-115010687-B Demulsifier, preparation method thereof and extraction process of vanillin 万华化学集团股份有限公司 2024-06-25 CN disclosed
US-20240159743-A1 METHODS FOR ASSESSING CELL SURFACE GLYCOSYLATION JUNO THERAPEUTICS, INC. (US) 2024-05-16 US disclosed
CN-113946103-B Dry film resist, method for manufacturing circuit wiring, input device, and display device 富士胶片株式会社 2024-05-07 CN disclosed
US-11796534-B2 Methods for assessing cell surface glycosylation JUNO THERAPEUTICS, INC. (US) 2023-10-24 US disclosed
CN-115260154-A Rapid fluorescent labeling of glycans and other biomolecules with enhanced MS signal 沃特世科技公司 2022-11-01 CN disclosed
US-11448652-B2 Rapid fluorescence tagging of glycans and other biomolecules with enhanced MS signals WATERS TECHNOLOGIES CORPORATION (US) 2022-09-20 US disclosed
EP-3974412-A1 RAPID FLUORESCENCE TAGGING OF GLYCANS AND OTHER BIOMOLECULES WITH ENHANCED MS SIGNALS Waters Technologies Corporation (US) 2022-03-30 EP disclosed
CN-106959585-B Positive photosensitive transfer material and method for producing circuit wiring 富士胶片株式会社 2022-02-25 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11448652-B2 Rapid fluorescence tagging of glycans and other biomolecules with enhanced MS signals FUT5, FUT6, CSGALNACT1 ALDH1A1 2639/4885KDM4E 4572/4885GLA 85/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.